[go: up one dir, main page]

ES2112555T3 - Composiciones farmaceuticas orales solubles en agua que contienen derivado de estrona y sales de calcio. - Google Patents

Composiciones farmaceuticas orales solubles en agua que contienen derivado de estrona y sales de calcio.

Info

Publication number
ES2112555T3
ES2112555T3 ES94925394T ES94925394T ES2112555T3 ES 2112555 T3 ES2112555 T3 ES 2112555T3 ES 94925394 T ES94925394 T ES 94925394T ES 94925394 T ES94925394 T ES 94925394T ES 2112555 T3 ES2112555 T3 ES 2112555T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
estrone
water soluble
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925394T
Other languages
English (en)
Inventor
Romano Deghenghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2112555T3 publication Critical patent/ES2112555T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

SE PRESENTAN COMPOSICIONES FARMACEUTICAS ORALES, SOLUBLES EN AGUA QUE CONTIENEN UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UN DERIVADO DE UN ESTROGENO ESTABLE Y SOLUBLE EN AGUA Y AL MENOS UNA SAL DE CALCIO SOLUBLE, FARMACOLOGICAMENTE ACEPTABLE EN LA PRESENCIA DE EXCIPIENTES ADECUADOS, FARMACOLOGICAMENTE ACEPTABLES.
ES94925394T 1993-09-17 1994-07-26 Composiciones farmaceuticas orales solubles en agua que contienen derivado de estrona y sales de calcio. Expired - Lifetime ES2112555T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932014A IT1270831B (it) 1993-09-17 1993-09-17 Composizioni farmaceutiche orali effervescenti contenenti estrone

Publications (1)

Publication Number Publication Date
ES2112555T3 true ES2112555T3 (es) 1998-04-01

Family

ID=11366921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925394T Expired - Lifetime ES2112555T3 (es) 1993-09-17 1994-07-26 Composiciones farmaceuticas orales solubles en agua que contienen derivado de estrona y sales de calcio.

Country Status (12)

Country Link
US (1) US5720977A (es)
EP (1) EP0719148B1 (es)
JP (1) JPH09502709A (es)
KR (1) KR100314338B1 (es)
AT (1) ATE163265T1 (es)
AU (1) AU7532994A (es)
CA (1) CA2171829A1 (es)
DE (1) DE69408579T2 (es)
ES (1) ES2112555T3 (es)
IL (1) IL110471A (es)
IT (1) IT1270831B (es)
WO (1) WO1995007701A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6726922B1 (en) 1999-06-28 2004-04-27 Minu, L.L.C. Process and composition for temporarily suppressing pain
CA2384104A1 (en) * 1999-09-08 2001-03-15 Melanie K. Spriggs Use of semaphorin for modulation of cellular efflux
ES2253451T3 (es) * 2000-12-14 2006-06-01 Ortho-Mcneil Pharmaceutical, Inc. Productos a base de hormona esteroide y sus procedimientos de fabricacion.
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP1971325A2 (en) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms

Also Published As

Publication number Publication date
IL110471A (en) 1998-10-30
DE69408579T2 (de) 1998-06-18
DE69408579D1 (de) 1998-03-26
ITMI932014A1 (it) 1995-03-17
ATE163265T1 (de) 1998-03-15
CA2171829A1 (en) 1995-03-23
EP0719148A1 (en) 1996-07-03
JPH09502709A (ja) 1997-03-18
AU7532994A (en) 1995-04-03
KR100314338B1 (ko) 2002-02-28
WO1995007701A1 (en) 1995-03-23
US5720977A (en) 1998-02-24
IL110471A0 (en) 1994-10-21
ITMI932014A0 (it) 1993-09-17
EP0719148B1 (en) 1998-02-18
IT1270831B (it) 1997-05-13

Similar Documents

Publication Publication Date Title
ES2129806T3 (es) Composiciones liquidas orales que contienen resinato de paroxetina.
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
AR064896A2 (es) Composicion farmaceutica no higroscopica
CO4750836A1 (es) Nuevos medicamentos y utilizacion (1-metiletil)-8-azoniabiciclo-[3.2.1]octnao y su uso en pre- paraciones medicas
DZ2453A1 (fr) Composition pharmaceutique pour administration orale d'un dérivé du n-pipéndin-3-pyrazolecarboxamidede ses sels et de leurs solvates.
FR2761265B1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
DK0510404T3 (da) Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
AR002350A1 (es) Composiciones farmacéuticas que contienen irbesartan
FI963984L (fi) Uusi oraalinen farmaseuttinen annostelumuoto
DK0402950T3 (da) Behandling af postmenopausale ulemper
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
MX9203236A (es) Composicion farmaceutica que comprende una ciclosporina.
FI972945L (fi) Antigeenien antamiseen soveltuvia koostumuksia
PA8453201A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
FI944978L (fi) Syklosporiinijohdannaista sisältävä farmaseuttinen koostumus
ATE255117T1 (de) Aminophosphonsäure-derivate als arzneimittel
ES2112555T3 (es) Composiciones farmaceuticas orales solubles en agua que contienen derivado de estrona y sales de calcio.
AR012853A1 (es) Formulacion inyectable transparente de compuesto anestesico
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
AU5763096A (en) Benzyl piperidine derivatives as pharmaceutical agents
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 719148

Country of ref document: ES